Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
about
Primary biliary cirrhosisQ24186229Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health PerspectiveRisk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsPrimary biliary cirrhosis: From bench to bedsidePrimary biliary cirrhosis: Pathophysiology, clinical presentation and therapyStratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study.Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidBiliary physiology and disease: reflections of a physician-scientist.Current status of therapy in autoimmune liver diseaseFunctional and structural features of cholangiocytes in health and disease.Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary CholangitisOverlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases.Natural history and management of primary biliary cirrhosis.Biochemical response to ursodeoxycholic acid predicts long-term outcome in Japanese patients with primary biliary cirrhosis.Treatment of primary biliary cirrhosis with ursodeoxycholic acid, budesonide and fibrates.Current pharmacotherapy for cholestatic liver disease.Long-term survival after perforated diverticulitis.Underestimated Male Prevalence of Primary Biliary Cholangitis in China: Results of a 16-yr cohort study involving 769 patientsLong-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis.Geoepidemiology and changing mortality in primary biliary cholangitis.Old and new treatments for primary biliary cholangitis.Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: Is it possible to predict the course of the disease?The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis.New developments in the treatment of primary biliary cholangitis - role of obeticholic acid.Recent developments in the management of idiopathic cholestatic liver diseaseNatural history of primary biliary cirrhosis.The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study.Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.A brief review on prognostic models of primary biliary cholangitis.Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor.Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study.A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.Guidelines for the management of primary biliary cirrhosisEarly biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study
P2860
Q21202919-A1279F93-7FD7-4AB8-BDFA-DCF11FD50201Q24186229-6FDB15B0-F893-4636-A753-8F589227BA65Q26781780-BCB34DBF-E8D3-430C-9FA9-87A7A232A490Q26796355-7880E67F-7E71-4407-812B-3F013345B2C1Q26799419-D8AE03BD-8124-496E-94BC-E07D88643AF2Q26853649-8708E790-8F44-4357-A1FC-0CDAC4E7235FQ33419647-1589B512-578B-4CF0-87E9-17CF2093568CQ33641759-70D61806-622B-48B6-BEBE-68F398923A5DQ33920325-9D7E06B7-178E-45FE-80D6-C5C6482CF690Q34108895-B8C36F8C-ADA5-4CF5-950A-90BD68D19843Q34408950-57E058FA-BF0E-452E-9638-1CBA27952257Q35933236-D6113F19-80DC-4F60-80BF-74B328643DB7Q36914749-0E65EBF6-2728-47CE-AD0B-27B4554B7E5FQ37346015-AAC43090-5F12-4E83-BF9D-746CCF23A88CQ37355843-E217FE98-609B-48FA-A70A-61C4B27E4136Q37855976-56EB42EC-E4E2-4DCB-A8A4-2370839864BBQ37892291-9F02A798-EF1C-407F-B97F-508A7AA4E691Q38055205-4DC40593-A54E-475C-9EED-485932E24B55Q38448011-D7EEACE0-BD13-4BCD-ACCF-4C91DAA27544Q38659201-A6DB2265-400B-41A1-B620-587BD0A7B04BQ38699595-C86306C5-A603-4303-B951-136C41288636Q39213467-1420FE6E-CD09-4B8C-9DD6-133EC147A3FFQ39216355-8384FB91-509B-4B71-B02A-978BA105D4EEQ39542696-3F083FEA-1562-4AF2-911A-C07DCFE6B14AQ41303819-C3F9C722-A30F-4459-9373-03624E9D8FB7Q41531249-ED8A247B-34D0-4B18-9ED8-6A9819582702Q42406650-AEA4CD46-F9FA-46D2-9ABF-C7678E2FEA8BQ46608065-4397CA57-E192-4292-9D5B-A1E7530C88AFQ46614923-761EBF45-FF8C-4C3E-AE40-0251A7833D44Q47787189-78402CEB-3E9D-447B-BAC6-2087826E71A1Q48342063-81CF567F-2F5B-49FD-8F3F-FEFEFAE8CF6DQ49153341-CD5B62DC-1023-4F79-BCCA-65187EB04924Q51108387-27618581-E1FA-47DE-BB8E-0C1AAF3BD00BQ51137626-D056E810-D8A0-4897-A2B5-9D6235E16E12Q53591523-CFDD41D9-017A-4378-AF8B-E25DF0F0A408Q56429943-CD76CE86-7D0F-470A-8594-3E7F3A9709FAQ57603219-5429934A-9BFE-4C69-9D0B-F96DE7516781
P2860
Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Prognosis of ursodeoxycholic A ...... study involving 297 patients.
@en
Prognosis of ursodeoxycholic A ...... study involving 297 patients.
@nl
type
label
Prognosis of ursodeoxycholic A ...... study involving 297 patients.
@en
Prognosis of ursodeoxycholic A ...... study involving 297 patients.
@nl
prefLabel
Prognosis of ursodeoxycholic A ...... study involving 297 patients.
@en
Prognosis of ursodeoxycholic A ...... study involving 297 patients.
@nl
P2093
P2860
P1476
Prognosis of ursodeoxycholic A ...... study involving 297 patients.
@en
P2093
Dutch PBC Study Group
Henk R van Buuren
Pieter C J ter Borg
Solko W Schalm
P2860
P304
P356
10.1111/J.1572-0241.2006.00699.X
P407
P50
P577
2006-07-18T00:00:00Z